• Something wrong with this record ?

Determination of pravastatin and pravastatin lactone in rat plasma and urine using UHPLC-MS/MS and microextraction by packed sorbent

H. Vlčková, M. Rabatinová, A. Mikšová, G. Kolouchová, S. Mičuda, P. Solich, L. Nováková,

. 2012 ; 90 () : 22-9. [pub] 20120109

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

A simple and reproducible method for the determination of pravastatin and pravastatin lactone in rat plasma and urine by means of ultrahigh performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) using deuterium labeled internal standards for quantification is reported. Separation of analytes was performed on BEH C(18) analytical column (50 mm × 2.1mm, 1.7 μm), using gradient elution by mobile phase consisting of acetonitrile and 1mM ammonium acetate at pH 4.0. Run time was 2 min. Quantification of analytes was performed using the SRM (selected reaction monitoring) experiment in ESI negative ion mode for pravastatin and in ESI positive ion mode for pravastatin lactone. Sample treatment consisted of a protein precipitation by ACN and microextraction by packed sorbent (MEPS) for rat plasma. Simple MEPS procedure was sufficient for rat urine. MEPS was implemented using the C8 sorbent inserted into a microvolume syringe, eVol hand-held automated analytical syringe and a small volume of sample (50 μl). The analytes were eluted by 100 μl of the mixture of acetonitrile: 0.01 M ammonium acetate pH 4.5 (90:10, v:v). The method was validated and demonstrated good linearity in range 5-500 nmol/l (r(2)>0.9990) for plasma and urine samples. Method recovery was ranged within 97-109% for plasma samples and 92-101% for the urine samples. Intra-day precision expressed as the % of RSD was lower than 8% for the plasma samples and lower than 7% for the urine samples. The method was validated with sensitivity reaching LOD 1.5 nmol/l and LOQ 5 nmol/l in plasma and urine samples. The method was applied for the measurement of pharmacokinetic plots of pravastatin and pravastatin lactone in rat plasma and urine samples.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12024023
003      
CZ-PrNML
005      
20121210105911.0
007      
ta
008      
120815e20120109enk f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.talanta.2011.12.043 $2 doi
035    __
$a (PubMed)22340111
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Vlčková, Hana $u Department of Analytical Chemistry, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
245    10
$a Determination of pravastatin and pravastatin lactone in rat plasma and urine using UHPLC-MS/MS and microextraction by packed sorbent / $c H. Vlčková, M. Rabatinová, A. Mikšová, G. Kolouchová, S. Mičuda, P. Solich, L. Nováková,
520    9_
$a A simple and reproducible method for the determination of pravastatin and pravastatin lactone in rat plasma and urine by means of ultrahigh performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) using deuterium labeled internal standards for quantification is reported. Separation of analytes was performed on BEH C(18) analytical column (50 mm × 2.1mm, 1.7 μm), using gradient elution by mobile phase consisting of acetonitrile and 1mM ammonium acetate at pH 4.0. Run time was 2 min. Quantification of analytes was performed using the SRM (selected reaction monitoring) experiment in ESI negative ion mode for pravastatin and in ESI positive ion mode for pravastatin lactone. Sample treatment consisted of a protein precipitation by ACN and microextraction by packed sorbent (MEPS) for rat plasma. Simple MEPS procedure was sufficient for rat urine. MEPS was implemented using the C8 sorbent inserted into a microvolume syringe, eVol hand-held automated analytical syringe and a small volume of sample (50 μl). The analytes were eluted by 100 μl of the mixture of acetonitrile: 0.01 M ammonium acetate pH 4.5 (90:10, v:v). The method was validated and demonstrated good linearity in range 5-500 nmol/l (r(2)>0.9990) for plasma and urine samples. Method recovery was ranged within 97-109% for plasma samples and 92-101% for the urine samples. Intra-day precision expressed as the % of RSD was lower than 8% for the plasma samples and lower than 7% for the urine samples. The method was validated with sensitivity reaching LOD 1.5 nmol/l and LOQ 5 nmol/l in plasma and urine samples. The method was applied for the measurement of pharmacokinetic plots of pravastatin and pravastatin lactone in rat plasma and urine samples.
650    _2
$a zvířata $7 D000818
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a laktony $x krev $x moč $7 D007783
650    _2
$a pravastatin $x krev $x moč $7 D017035
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a mikroextrakce na pevné fázi $x metody $7 D052617
650    _2
$a tandemová hmotnostní spektrometrie $x metody $7 D053719
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rabatinová, Martina
700    1_
$a Mikšová, Alena
700    1_
$a Kolouchová, Gabriela
700    1_
$a Mičuda, Stanislav
700    1_
$a Solich, Petr
700    1_
$a Nováková, Lucie
773    0_
$w MED00004484 $t Talanta $x 1873-3573 $g Roč. 90(20120109), s. 22-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22340111 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120815 $b ABA008
991    __
$a 20121210105947 $b ABA008
999    __
$a ok $b bmc $g 946171 $s 781351
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 90 $d 22-9 $e 20120109 $i 1873-3573 $m Talanta $n Talanta $x MED00004484
LZP    __
$a Pubmed-20120815/12/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...